TP53 and colorectal cancer: We observed nominally significant differences (p < 0.05; univariate Cox regression analysis) in survival for BRCA2 and TP53 in multiple cancer types as well as for UVRAG in colorectal cancer (Figure 3—figure supplements 2 and 3; Supplementary file 1j).